CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Magun, B. E.
Right arrow Articles by Rodland, K. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Magun, B. E.
Right arrow Articles by Rodland, K. D.

Cell Growth & Differentiation, Vol 6, Issue 7 891-897, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Transient inhibition of protein synthesis induces the immediate early gene VL30: alternative mechanism for thapsigargin-induced gene expression

BE Magun and KD Rodland
Department of Cell Biology and Anatomy, Oregon Health Sciences University, Portland 97201-3098, USA.

Induction of gene expression in response to calcium ionophores or thapsigargin, which inhibits the calcium-ATPase responsible for sequestering intracellular calcium, has frequently been attributed to direct stimulatory events subsequent to the elevation of intracellular free calcium. VL30 is a murine gene that is transcriptionally induced in response to a large array of mitogenic and transforming stimuli. We have shown previously that an enhancer element within the VL30 promoter region is dependent upon cotreatment with thapsigargin or calcium ionophore for a full-scale induction of gene expression. In this report, we demonstrate that both thapsigargin and calcium ionophores induce a transient inhibition of protein synthesis in Rat-1 cells transfected with a VL30 enhancer-driven reporter construct. Recovery of protein synthesis is facilitated by cotreatment with epidermal growth factor or phorbol esters. Furthermore, treatment with cycloheximide or DTT, which inhibit protein synthesis without altering intracellular calcium levels, can substitute for thapsigargin or ionophores in stimulating VL30 gene expression. These results suggest that the stimulatory effects of thapsigargin and calcium ionophores on VL30 expression may be mediated, at least in part, by the ability of these agents to initiate stress responses associated with inhibition of protein synthesis.


This article has been cited by other articles:


Home page
Biochem. J.Home page
S.-H. Liang, W. Zhang, B. C. Mcgrath, P. Zhang, and D. R. Cavener
PERK (eIF2{alpha} kinase) is required to activate the stress-activated MAPKs and induce the expression of immediate-early genes upon disruption of ER calcium homoeostasis
Biochem. J., January 1, 2006; 393(1): 201 - 209.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. S. Iordanov, D. Pribnow, J. L. Magun, T.-H. Dinh, J. A. Pearson, and B. E. Magun
Ultraviolet Radiation Triggers the Ribotoxic Stress Response in Mammalian Cells
J. Biol. Chem., June 19, 1998; 273(25): 15794 - 15803.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. S. Iordanov and B. E. Magun
Loss of Cellular K+ Mimics Ribotoxic Stress: INHIBITION OF PROTEIN SYNTHESIS AND ACTIVATION OF THE STRESS KINASES SEK1/MKK4, STRESS-ACTIVATED PROTEIN KINASE/c-Jun NH2-TERMINAL KINASE 1, AND p38/HOG1 BY PALYTOXIN
J. Biol. Chem., February 6, 1998; 273(6): 3528 - 3534.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
J.-M. Brondello, A. Brunet, J. Pouyssegur, and F. R. McKenzie
The Dual Specificity Mitogen-activated Protein Kinase Phosphatase-1 and -2 Are Induced by the p42/p44MAPK Cascade
J. Biol. Chem., January 10, 1997; 272(2): 1368 - 1376.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.